Dr. David Finley
Claim this profileDartmouth Hitchcock Medical Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
4 drugs studied
Affiliated Hospitals
More about David Finley
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments David Finley has experience with
- Durvalumab
- Platinum Doublet Chemotherapy
- Radiotherapy
- Surgery
Breakdown of trials David Finley has run
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Finley specialize in?
David Finley focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are undergoing treatment.
Is David Finley currently recruiting for clinical trials?
No, David Finley is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that David Finley has studied deeply?
Yes, David Finley has studied treatments such as Durvalumab, Platinum Doublet Chemotherapy, Radiotherapy.
What is the best way to schedule an appointment with David Finley?
Apply for one of the trials that David Finley is conducting.
What is the office address of David Finley?
The office of David Finley is located at: Dartmouth Hitchcock Medical Center, Manchester, New Hampshire 03103 United States. This is the address for their practice at the Dartmouth Hitchcock Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.